Take into the conversation
Questions to ask
- Is the service referring to the former brand or to a pharmacy-made product?
- Which use did the old approval cover?
- What evidence supports the use being proposed to me?
The notes behind the questions
What the answer rests on
There was an approved brand
FDA means Food and Drug Administration.
Sermorelin (Geref) received FDA approval in December 1990 to test whether the pituitary, a gland below the brain, could release growth hormone, the body's growth signal.
That test used the drug to see how the gland responded; it was not a routine blood test before treatment.
In September 1997, FDA also approved it for children who were not growing properly because they lacked growth hormone.
As of 28 September 2026, there has never been an approved adult use for sermorelin.
Those approvals ended
The maker stopped selling Geref and asked FDA to end its approvals; FDA ended them on 18 June 2009.
In March 2013, FDA concluded that neither safety nor effectiveness problems had caused Geref to leave the market.
That finding concerns why the old product stopped being sold; it is not FDA saying the products offered now are safe or work.
A current offer is a different question
FDA records checked on 28 September 2026 show no FDA-approved version of sermorelin on sale in the US.
Compounding means a pharmacy makes a medicine to order.
As of 26 September 2026, a compounded product has no FDA approval, even when made under the compounding rules.
Keep in your notes
When a page uses the word approved, ask it to name the product and the use. A history of approval and a present-day prescription answer different questions.